Literature DB >> 9514594

Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel.

J M Meyer1, J C Breitner.   

Abstract

The three common alleles at the APOE locus influence the onset and lifetime risk of typical late-onset Alzheimer's disease (AD). Other loci may also alter risk of late-onset AD. One may assess the relative influence of APOE on the genetic contribution to AD by estimating the proportion of AD heritability that is explained by APOE polymorphism. To do this requires an initial estimate of the heritability of AD. Traditional methods are not appropriate for this estimation since they do not consider right-censoring (incomplete expression of the genotype owing to death) nor do they model the relation of onset age and disease liability. Here we present an analytic model that addresses both of these issues. Genetic and environmental influences on AD are examined by assuming that onset of dementia in AD is a late event in an extended degenerative process where earlier onset reflects a more rapid course of neurodegeneration. The model is fitted to the occurrence of AD among 9,786 members of the National Academy of Sciences-National Research Council Registry of aging veteran twins. When both additive genetic and common environmental effects are used in the model, they explain 37% and 35%, respectively, of the variation in AD onset. Given the limited numbers of AD cases now available, models containing only additive genetic or shared environmental effects (explaining 75% and 65% of individual differences in disease onset, respectively) cannot be rejected in favor of a model that retains both influences.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514594     DOI: 10.1002/(sici)1096-8628(19980207)81:1<92::aid-ajmg16>3.0.co;2-r

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  20 in total

1.  Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.

Authors:  Jason J Corneveaux; Amanda J Myers; April N Allen; Jeremy J Pruzin; Manuel Ramirez; Anzhelika Engel; Michael A Nalls; Kewei Chen; Wendy Lee; Kendria Chewning; Stephen E Villa; Hunsar B Meechoovet; Jill D Gerber; Danielle Frost; Hollie L Benson; Sean O'Reilly; Lori B Chibnik; Joshua M Shulman; Andrew B Singleton; David W Craig; Kendall R Van Keuren-Jensen; Travis Dunckley; David A Bennett; Philip L De Jager; Christopher Heward; John Hardy; Eric M Reiman; Matthew J Huentelman
Journal:  Hum Mol Genet       Date:  2010-06-09       Impact factor: 6.150

2.  The sociobiologic integrative model (SBIM): enhancing the integration of sociobehavioral, environmental, and biomolecular knowledge in urban health and disparities research.

Authors:  M Chris Gibbons; Malcolm Brock; Anthony J Alberg; Thomas Glass; Thomas A LaVeist; Stephen Baylin; David Levine; C Earl Fox
Journal:  J Urban Health       Date:  2007-03       Impact factor: 3.671

3.  Genome scan of age-at-onset in the NIMH Alzheimer disease sample uncovers multiple loci, along with evidence of both genetic and sample heterogeneity.

Authors:  Yoonha Choi; Elizabeth E Marchani; Thomas D Bird; Ellen J Steinbart; Deborah Blacker; Ellen M Wijsman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-08-02       Impact factor: 3.568

Review 4.  Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects.

Authors:  Sumeet Kumar; Navneesh Yadav; Sanjay Pandey; B K Thelma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

5.  Variants regulating ZBTB4 are associated with age-at-onset of Alzheimer's disease.

Authors:  E E Blue; C-E Yu; T A Thornton; N H Chapman; E Kernfeld; N Jiang; K M Shively; K J Buckingham; C T Marvin; M J Bamshad; T D Bird; E M Wijsman
Journal:  Genes Brain Behav       Date:  2017-11-20       Impact factor: 3.449

Review 6.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

7.  Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2.

Authors:  Ellen M Wijsman; E Warwick Daw; Change-En Yu; Haydeh Payami; Ellen J Steinbart; David Nochlin; Erin M Conlon; Thomas D Bird; Gerard D Schellenberg
Journal:  Am J Hum Genet       Date:  2004-07-08       Impact factor: 11.025

8.  GAB2 as an Alzheimer disease susceptibility gene: follow-up of genomewide association results.

Authors:  Brit-Maren M Schjeide; Basavaraj Hooli; Michele Parkinson; Meghan F Hogan; Jason DiVito; Kristina Mullin; Deborah Blacker; Rudolph E Tanzi; Lars Bertram
Journal:  Arch Neurol       Date:  2009-02

Review 9.  Chasing genes in Alzheimer's and Parkinson's disease.

Authors:  Aida M Bertoli-Avella; Ben A Oostra; Peter Heutink
Journal:  Hum Genet       Date:  2004-03-04       Impact factor: 4.132

Review 10.  Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.